Literature DB >> 32876922

Hospital robotic use for colorectal cancer care.

Aaron C Spaulding1,2, Hanadi Hamadi3, Osayande Osagiede4, Riccardo Lemini5,6, Jordan J Cochuyt7, John Watson6, James M Naessens5,8, Dorin T Colibaseanu5,6.   

Abstract

The use of robotic surgery for colorectal cancer continues to increase. However, not all organizations offer patients the option of robotic intervention. This study seeks to understand organizational characteristics associated with the utilization of robotic surgery for colorectal cancer. We conducted a retrospective study of hospitals identified in the United States, State of Florida Inpatient Discharge Dataset, and linked data for those hospitals with the American Hospital Association Survey, Area Health Resource File and the Health Community Health Assessment Resource Tool Set. The study population included all robotic surgeries for colorectal cancer patients in 159 hospitals from 2013 to 2015. Logistic regressions identifying organizational, community, and combined community and organizational variables were utilized to determine associations. Results indicate that neither hospital competition nor disease burden in the community was associated with increased odds of robotic surgery use. However, per capita income (OR 1.07 95% CI 1.02, 1.12), average total margin (OR 1.01, 95% CI 1.001, 1.02) and large-sized hospitals compared to small hospitals (OR: 5.26, 95% CI 1.13, 24.44) were associated with increased odds of robotic use. This study found that market conditions within the U.S. State of Florida are not primary drivers of hospital use of robotic surgery. The ability for the population to pay for such services, and the hospital resources available to absorb the expense of purchasing the required equipment, appear to be more influential.
© 2020. Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Colorectal cancer; Community characteristics; Hospital characteristics; Market conditions; Robotic surgery

Year:  2020        PMID: 32876922     DOI: 10.1007/s11701-020-01142-y

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  7 in total

1.  Disparities in minimally invasive surgery for colorectal cancer in Florida.

Authors:  Osayande Osagiede; Aaron C Spaulding; Jordan J Cochuyt; James M Naessens; Amit Merchea; Pashtoon M Kasi; Marie Crandall; Dorin T Colibaseanu
Journal:  Am J Surg       Date:  2018-11-27       Impact factor: 2.565

2.  Comparison of pathological outcomes between robotic rectal cancer surgery and laparoscopic rectal cancer surgery: A meta-analysis based on seven randomized controlled trials.

Authors:  Guixiang Liao; Zhihong Zhao; Haijun Deng; Xianming Li
Journal:  Int J Med Robot       Date:  2019-08-22       Impact factor: 2.547

3.  A comprehensive review of robotic surgery curriculum and training for residents, fellows, and postgraduate surgical education.

Authors:  Richard Chen; Priscila Rodrigues Armijo; Crystal Krause; Ka-Chun Siu; Dmitry Oleynikov
Journal:  Surg Endosc       Date:  2019-04-05       Impact factor: 4.584

4.  Robotic Versus Laparoscopic Rectal Surgery for Rectal Cancer: A Meta-Analysis of 7 Randomized Controlled Trials.

Authors:  Laiyuan Li; Weisheng Zhang; Yinyin Guo; Xiaolin Wang; Huichuan Yu; Binbin Du; Xiongfei Yang; Yanxin Luo
Journal:  Surg Innov       Date:  2019-05-12       Impact factor: 2.058

Review 5.  The role of robotics in colorectal surgery.

Authors:  Christina L Cheng; Craig Rezac
Journal:  BMJ       Date:  2018-02-12

6.  Comparing pathologic outcomes for robotic versus laparoscopic Surgery in rectal cancer resection: a propensity adjusted analysis of 7616 patients.

Authors:  M Benjamin Hopkins; Timothy M Geiger; Alva J Bethurum; Molly M Ford; Roberta L Muldoon; David E Beck; Thomas G Stewart; Alexander T Hawkins
Journal:  Surg Endosc       Date:  2019-07-25       Impact factor: 4.584

7.  Impact of age and comorbidity on survival in colorectal cancer.

Authors:  Elmer E van Eeghen; Sandra D Bakker; Aart van Bochove; Ruud J L F Loffeld
Journal:  J Gastrointest Oncol       Date:  2015-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.